AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
In vivo surgical resection plus adjuvant gene therapy in the treatment of mammary and prostate cancer
Authors: Sukin, SW Chhikara, M Zhu, XH Ayala, G Aguilar, LK Smith, EO Miles, BJ Thompson, TC Kadmon, D Aguilar-Cordova, E
Citation: Sw. Sukin et al., In vivo surgical resection plus adjuvant gene therapy in the treatment of mammary and prostate cancer, MOL THER, 3(4), 2001, pp. 500-506
Enhanced therapeutic effect of HSV-tk plus GCV gene therapy and ionizing radiation for prostate cancer
Authors: Chhikara, M Huang, HX Vlachaki, MT Zhu, XH Teh, B Chiu, KJ Woo, S Berner, B Smith, EO Oberg, KC Aguilar, LK Thompson, TC Butler, EB Aguilar-Cordova, E
Citation: M. Chhikara et al., Enhanced therapeutic effect of HSV-tk plus GCV gene therapy and ionizing radiation for prostate cancer, MOL THER, 3(4), 2001, pp. 536-542
Prostate-specific antigen response and systemic T cell activation after insitu gene therapy in prostate cancer patients failing radiotherapy
Authors: Miles, BJ Shalev, M Aguilar-Cordova, E Timme, TL Lee, HM Yang, G Adler, HL Kernen, K Pramudji, CK Satoh, T Gdor, Y Ren, CZ Ayala, G Wheeler, TM Butler, EB Kadmon, D Thompson, TC
Citation: Bj. Miles et al., Prostate-specific antigen response and systemic T cell activation after insitu gene therapy in prostate cancer patients failing radiotherapy, HUM GENE TH, 12(16), 2001, pp. 1955-1967
Coxsackievirus-adenovirus receptor expression in ovarian cancer cell linesis associated with increased adenovirus transduction efficiency and transgene expression
Authors: You, ZB Fischer, DC Tong, XW Hasenburg, A Aguilar-Cordova, E Kieback, DG
Citation: Zb. You et al., Coxsackievirus-adenovirus receptor expression in ovarian cancer cell linesis associated with increased adenovirus transduction efficiency and transgene expression, CANC GENE T, 8(3), 2001, pp. 168-175
Enhanced therapeutic effect of multiple injections of HSV-TK plus GCV genetherapy in combination with ionizing radiation in a mouse mammary tumor model
Authors: Vlachaki, MT Chhikara, M Aguilar, L Zhu, XH Chiu, KJ Woo, S Teh, BS Thompson, TC Butler, EB Aguilar-Cordova, E
Citation: Mt. Vlachaki et al., Enhanced therapeutic effect of multiple injections of HSV-TK plus GCV genetherapy in combination with ionizing radiation in a mouse mammary tumor model, INT J RAD O, 51(4), 2001, pp. 1008-1017
Phase I/II trial evaluating combined radiotherapy and in situ gene therapywith or without hormonal therapy in the treatment of prostate cancer - A preliminary report
Authors: Teh, BS Aguilar-Cordova, E Kernen, K Chou, CC Shalev, M Vlachaki, MT Miles, B Kadmon, D Mai, WY Caillouet, J Davis, M Ayala, G Wheeler, T Brady, J Carpenter, LS Lu, HH Chiu, JK Woo, SY Thompson, T Butler, EB
Citation: Bs. Teh et al., Phase I/II trial evaluating combined radiotherapy and in situ gene therapywith or without hormonal therapy in the treatment of prostate cancer - A preliminary report, INT J RAD O, 51(3), 2001, pp. 605-613
Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: A potential treatment strategy for Epstein-Barr virus-positive Hodgkin's lymphoma
Authors: Gahn, B Siller-Lopez, F Pirooz, AD Yvon, E Gottschalk, S Longnecker, R Brenner, MK Heslop, HE Aguilar-Cordova, E Rooney, CM
Citation: B. Gahn et al., Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: A potential treatment strategy for Epstein-Barr virus-positive Hodgkin's lymphoma, INT J CANC, 93(5), 2001, pp. 706-713
Working toward an adenoviral vector testing standard
Authors: Hutchins, B Sajjadi, N Seaver, S Shepherd, A Bauer, SR Simek, S Carson, K Aguilar-Cordova, E
Citation: B. Hutchins et al., Working toward an adenoviral vector testing standard, MOL THER, 2(6), 2000, pp. 532-534
Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy
Authors: Salgado, S Garcia, J Vera, J Siller, F Bueno, M Miranda, A Segura, A Grijalva, G Segura, J Orozco, H Hernandez-Pando, R Fafutis, M Aguilar, LK Aguilar-Cordova, E Armendariz-Borunda, J
Citation: S. Salgado et al., Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy, MOL THER, 2(6), 2000, pp. 545-551
Multiplicity of infection/multiplicity of confusion
Authors: Shabram, P Aguilar-Cordova, E
Citation: P. Shabram et E. Aguilar-cordova, Multiplicity of infection/multiplicity of confusion, MOL THER, 2(5), 2000, pp. 420-421
A prescription for gene therapy
Authors: Aguilar, LK Aguilar-Cordova, E Ando, D Armendariz-Borunda, J Burd, PR Butler, EB Carter, B Chiang, YL Glorioso, JC Henderson, DR Jolly, D McKenny, GP Nemunaitis, J Rives, M Scherer, S Woo, SLC
Citation: Lk. Aguilar et al., A prescription for gene therapy, MOL THER, 1(5), 2000, pp. 385-388
Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with recurrent malignant brain tumors
Authors: Trask, TW Trask, RP Aguilar-Cordova, E Shine, HD Wyde, PR Goodman, JC Hamilton, WJ Rojas-Martinez, A Chen, SH Woo, SLC Grossman, RG
Citation: Tw. Trask et al., Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with recurrent malignant brain tumors, MOL THER, 1(2), 2000, pp. 195-203
Reporting adverse events in gene therapy studies
Authors: Grilley, BJ Aguilar, LK Aguilar-Cordova, E
Citation: Bj. Grilley et al., Reporting adverse events in gene therapy studies, BIODRUGS, 14(3), 2000, pp. 141-145
A phase I study of intralesional administration of an adenovirus vector expressing the HSV-1 thymidine kinase gene (AdV.RSV-TK) in combination with escalating doses of ganciclovir in patients with cutaneous metastatic malignant melanoma
Authors: Morris, JC Ramsey, WJ Wildner, O Muslow, HA Aguilar-Cordova, E Blaese, RM
Citation: Jc. Morris et al., A phase I study of intralesional administration of an adenovirus vector expressing the HSV-1 thymidine kinase gene (AdV.RSV-TK) in combination with escalating doses of ganciclovir in patients with cutaneous metastatic malignant melanoma, HUM GENE TH, 11(3), 2000, pp. 487-503
Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancer
Authors: Hasenburg, A Tong, XW Rojas-Martinez, A Nyberg-Hoffman, C Kieback, CC Kaplan, A Kaufman, RH Ramzy, I Aguilar-Cordova, E Kieback, DG
Citation: A. Hasenburg et al., Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancer, CANC GENE T, 7(6), 2000, pp. 839-844
Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene
Authors: Shalev, M Miles, BJ Thompson, TC Ayala, G Butler, EB Aguilar-Cordova, E Kadmon, D
Citation: M. Shalev et al., Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene, WORLD J URO, 18(2), 2000, pp. 125-129
Truncated active matrix metalloproteinase-8 gene expression in HepG2 cellsis active against native type I collagen
Authors: Siller-Lopez, F Garcia-Banuelos, J Hasty, KA Segura, J Ramos-Marquez, M Qoronfleh, MW Aguilar-Cordova, E Armendariz-Borunda, J
Citation: F. Siller-lopez et al., Truncated active matrix metalloproteinase-8 gene expression in HepG2 cellsis active against native type I collagen, J HEPATOL, 33(5), 2000, pp. 758-763
Cytopathic effect of in situ gene therapy in prostate cancer
Authors: Ayala, G Wheeler, TM Shalev, M Thompson, TC Miles, B Aguilar-Cordova, E Chakraborty, S Kadmon, D
Citation: G. Ayala et al., Cytopathic effect of in situ gene therapy in prostate cancer, HUMAN PATH, 31(7), 2000, pp. 866-870
Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer
Authors: Shalev, M Kadmon, D Teh, BS Butler, EB Aguilar-Cordova, E Thompson, TC Herman, JR Adler, HL Scardino, PT Miles, BJ
Citation: M. Shalev et al., Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer, J UROL, 163(6), 2000, pp. 1747-1750
Instability of adenoviral vectors during transport and its implication forclinical studies
Authors: Nyberg-Hoffman, C Aguilar-Cordova, E
Citation: C. Nyberg-hoffman et E. Aguilar-cordova, Instability of adenoviral vectors during transport and its implication forclinical studies, NAT MED, 5(8), 1999, pp. 955-957
Gene transfer for therapy or enhancement
Authors: McKenny, GP Aguilar-Cordova, E
Citation: Gp. Mckenny et E. Aguilar-cordova, Gene transfer for therapy or enhancement, HUM GENE TH, 10(9), 1999, pp. 1429-1430
In situ gene therapy for adenocarcinoma of the prostate: A phase I clinical trial
Authors: Herman, JR Adler, HL Aguilar-Cordova, E Rojas-Martinez, A Woo, S Timme, TL Wheeler, TM Thompson, TC Scardino, PT
Citation: Jr. Herman et al., In situ gene therapy for adenocarcinoma of the prostate: A phase I clinical trial, HUM GENE TH, 10(7), 1999, pp. 1239-1249
Suicide gene therapy for treatment of retinoblastoma in a murine model
Authors: Hurwitz, MY Marcus, KT Chevez-Barrios, P Louie, K Aguilar-Cordova, E Hurwitz, RL
Citation: My. Hurwitz et al., Suicide gene therapy for treatment of retinoblastoma in a murine model, HUM GENE TH, 10(3), 1999, pp. 441-448
Thymidine kinase (TK) gene therapy of solid tumors: Valacyclovir facilitates outpatient treatment
Authors: Hasenburg, A Tong, XW Rojas-Martinez, A Nyberg-Hoffman, C Kieback, CC Kaplan, AL Kaufman, RH Ramzy, I Aguilar-Cordova, E Kieback, DG
Citation: A. Hasenburg et al., Thymidine kinase (TK) gene therapy of solid tumors: Valacyclovir facilitates outpatient treatment, ANTICANC R, 19(3B), 1999, pp. 2163-2165
Hepatocyte gene therapy in a large animal: A neonatal bovine model of citrullinemia
Authors: Lee, B Dennis, JA Healy, PJ Mull, B Pastore, L Yu, H Aguilar-Cordova, E O'Brien, W Reeds, P Beaudet, AL
Citation: B. Lee et al., Hepatocyte gene therapy in a large animal: A neonatal bovine model of citrullinemia, P NAS US, 96(7), 1999, pp. 3981-3986
Risultati: 1-25 | 26-29